Data / Form D filings / ABT Molecular Imaging, Inc.
ABT Molecular Imaging, Inc.: Form D filings
ABT Molecular Imaging, Inc., a biotechnology company in Louisville, TN, filed 10 Form D notices with the SEC between 2009 and 2014. The latest, on August 21, 2014, reports $750,000 sold of a $1.3 million offering to 3 investors.
Find out what ABT Molecular Imaging, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3024 TOPSIDE BUSINESS PARK, Louisville, TN, 37777
- Phone
- (865) 604-4880
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1473539
The full lists. Form D filings in Tennessee: 543 rows, $27.15, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 21, 2014 | New notice | $1,259,858 | $750,000 | $509,858 | 3 | Jun 24, 2014 | sec.gov |
| May 12, 2014 | New notice | $1,062,939 | $775,000 | $287,939 | 3 | May 9, 2014 | sec.gov |
| Apr 3, 2014 | New notice | $1,097,227 | $800,000 | $297,227 | 3 | Mar 27, 2014 | sec.gov |
| Feb 25, 2014 | New notice | $685,768 | $500,000 | $185,768 | 3 | Feb 18, 2014 | sec.gov |
| Dec 4, 2013 | New notice | $550,000 | $401,010 | $148,990 | 3 | Nov 29, 2013 | sec.gov |
| Sep 10, 2012 | New notice | $6,053,150 | $6,053,150 | $0 | 5 | Sep 4, 2012 | sec.gov |
| Aug 8, 2012 | New notice | $150,000 | $150,000 | $0 | 1 | Aug 7, 2012 | sec.gov |
| Mar 5, 2012 | New notice | $500,000 | $500,000 | $0 | 1 | Feb 29, 2012 | sec.gov |
| Jun 29, 2011 | New notice | $4,013,808 | $4,013,808 | $0 | 1 | Jun 20, 2011 | sec.gov |
| Oct 6, 2009 | New notice | $8,999,999 | $6,000,000 | $2,999,999 | 2 | Sep 23, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Templin | Executive Officer | |
| Peter Kingma | Executive Officer, Director | |
| Dennis Dougherty | Director | |
| Rik Vandevenne | Director |
Other biotechnology companies in Tennessee that filed recently
- Synomis, Inc. $30,000 · Oct 30, 2026
- TM Holding Companies, Inc. $3.7 million · Oct 8, 2026
Every Form D from the week of Aug 18, 2014 · All recent filings in Tennessee · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ABT Molecular Imaging, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.